Future prospects for alemtuzumab (MabCampath). (Q34785898)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Future prospects for alemtuzumab (MabCampath).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Future prospects for alemtuzumab (MabCampath). (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

2

object named as

Michael Hallek

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Kanti Rai

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

19 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

S57-63

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

In vivo 'Purging' of residual disease in CLL with Campath-1H

1 reference

https://pubmed.ncbi.nlm.nih.gov/12180493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12180493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period

1 reference

https://pubmed.ncbi.nlm.nih.gov/12180493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12180493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative real-time polymerase chain reaction for the core facility using TaqMan and the Perkin-Elmer/Applied Biosystems Division 7700 Sequence Detector

1 reference

https://pubmed.ncbi.nlm.nih.gov/12180493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12180493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12180493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/MO:19:2S:S57

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34785898&oldid=2197036591"